Annual report pursuant to Section 13 and 15(d)

Quarterly Financial Data - Unaudited - Schedule of Quarterly Financial Data - Unaudited (Detail)

v3.5.0.2
Quarterly Financial Data - Unaudited - Schedule of Quarterly Financial Data - Unaudited (Detail)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 12 Months Ended
Sep. 24, 2016
USD ($)
JointVenture
$ / shares
shares
Jun. 25, 2016
USD ($)
$ / shares
shares
Mar. 26, 2016
USD ($)
$ / shares
shares
Dec. 26, 2015
USD ($)
$ / shares
shares
Sep. 26, 2015
USD ($)
$ / shares
shares
Jun. 27, 2015
USD ($)
$ / shares
shares
Mar. 28, 2015
USD ($)
$ / shares
shares
Dec. 27, 2014
USD ($)
$ / shares
shares
Sep. 24, 2016
USD ($)
JointVenture
$ / shares
shares
Sep. 26, 2015
USD ($)
$ / shares
shares
Sep. 27, 2014
USD ($)
$ / shares
shares
Quarterly Financial Information Disclosure [Abstract]                      
Net sales $ 413,412 $ 514,544 $ 541,249 $ 359,812 $ 386,369 $ 459,446 $ 497,602 $ 307,320 $ 1,829,017 $ 1,650,737 $ 1,604,357
Gross profit 120,180 163,745 169,339 99,786 107,972 142,037 150,062 87,981 553,050 488,052 454,024
Net income (loss) attributable to Central Garden & Pet Company $ (5,611) $ 26,030 $ 32,697 $ (8,602) $ (4,369) $ 18,800 $ 23,237 $ (5,697) $ 44,514 $ 31,971 $ 8,804
Net income per share attributable to Central Garden & Pet Company:                      
Basic (in usd per share) | $ / shares $ (0.11) $ 0.53 $ 0.67 $ (0.18) $ (0.09) $ 0.39 $ 0.48 $ (0.12) $ 0.91 $ 0.66 $ 0.18
Diluted (in usd per share) | $ / shares $ (0.11) $ 0.51 $ 0.65 $ (0.18) $ (0.09) $ 0.38 $ 0.47 $ (0.12) $ 0.87 $ 0.64 $ 0.18
Weighted average common shares outstanding:                      
Basic (in shares) | shares 49,453 49,120 48,717 48,566 48,322 48,167 48,384 49,379 48,964 48,562 48,880
Diluted (in shares) | shares 49,453 51,063 50,445 48,566 48,322 49,290 49,439 49,379 51,075 49,638 49,397
Debt instrument, redemption, incremental expense       $ 14,300              
Debt instrument, redemption, incremental expense, call premium       8,300              
Debt instrument, redemption, incremental expense, overlapping interest expenses       $ 2,700              
Debt instrument, redemption, incremental expense, overlapping interest expenses, period       30 days              
Write-off of deferred financing costs       $ 3,300         $ 3,337 $ 537 $ 1,731
Gain on sale of manufacturing plant assets   $ 2,400                  
Non-cash impairment charge $ 16,600               $ 19,367 7,272 $ 5,870
Number of joint ventures | JointVenture 2               2    
Non-cash impairment charge to indefinite-lived intangible assets $ 1,800       $ 7,300       $ 1,800 $ 7,300